Similarly, miR-483-3p that targets Lamin-B receptor (LBR) and has been associated with cancer progression, is assessed as a potential marker due to substantial upregulation in the plasma of AD patients as compared to normal controls that provide a new approach to the clinical diagnosis of AE (Ren et al. 2019). The gene discussed is LBR; the disease is cancer.